1. Sorafenib and everolimus in patients with advanced solid tumors and KRAS‐mutated NSCLC: A phase I trial with early pharmacodynamic FDG‐PET assessment. (21st May 2020) Authors: Nogova, Lucia; Mattonet, Christian; Scheffler, Matthias; Taubert, Max; Gardizi, Masyar; Sos, Martin L.; Michels, Sebastian; Fischer, Rieke N.; Limburg, Meike; Abdulla, Diana S.Y.; Persigehl, Thorsten; Kobe, Carsten; Merkelbach‐Bruse, Sabine; Franklin, Jeremy; Backes, Heiko; Schnell, Roland; Behri... Journal: Cancer medicine Issue: Volume 9:Number 14(2020) Page Start: 4991 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗